Have a feature idea you'd love to see implemented? Let us know!

USPH U S Physical Therapy Inc

Price (delayed)

$95.08

Market cap

$1.44B

P/E Ratio

108.05

Dividend/share

$1.75

EPS

$0.88

Enterprise value

$1.57B

Founded in 1990, U.S. Physical Therapy, Inc. operates 548 outpatient physical therapy clinics in 39 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders ...

Highlights
U S Physical Therapy's revenue has increased by 9% YoY and by 2.9% from the previous quarter
The company's gross profit rose by 2.6% YoY
The P/E is 110% higher than the 5-year quarterly average of 51.4 and 21% higher than the last 4 quarters average of 89.5
USPH's EPS is down by 49% YoY and by 12% from the previous quarter

Key stats

What are the main financial stats of USPH
Market
Shares outstanding
15.09M
Market cap
$1.44B
Enterprise value
$1.57B
Valuations
Price to book (P/B)
2.97
Price to sales (P/S)
2.22
EV/EBIT
38.36
EV/EBITDA
27.07
EV/Sales
2.44
Earnings
Revenue
$645.7M
EBIT
$40.99M
EBITDA
$58.1M
Free cash flow
$73.45M
Per share
EPS
$0.88
Free cash flow per share
$4.87
Book value per share
$32.02
Revenue per share
$42.83
TBVPS
$23.23
Balance sheet
Total assets
$1.03B
Total liabilities
$358.47M
Debt
$254.35M
Equity
$482.76M
Working capital
$89.57M
Liquidity
Debt to equity
0.53
Current ratio
1.78
Quick ratio
1.68
Net debt/EBITDA
2.36
Margins
EBITDA margin
9%
Gross margin
18.9%
Net margin
3.5%
Operating margin
7.4%
Efficiency
Return on assets
2.2%
Return on equity
4.7%
Return on invested capital
10.7%
Return on capital employed
4.5%
Return on sales
6.3%
Dividend
Dividend yield
1.84%
DPS
$1.75
Payout ratio
175%

USPH stock price

How has the U S Physical Therapy stock price performed over time
Intraday
-0.2%
1 week
16.83%
1 month
22.72%
1 year
14.89%
YTD
2.08%
QTD
12.35%

Financial performance

How have U S Physical Therapy's revenue and profit performed over time
Revenue
$645.7M
Gross profit
$121.91M
Operating income
$47.8M
Net income
$22.84M
Gross margin
18.9%
Net margin
3.5%
U S Physical Therapy's net margin has decreased by 31% YoY and by 15% from the previous quarter
The operating margin has declined by 27% year-on-year and by 5% since the previous quarter
The company's net income fell by 24% YoY and by 10% QoQ
The operating income is down by 20% year-on-year and by 2.3% since the previous quarter

Growth

What is U S Physical Therapy's growth rate over time

Valuation

What is U S Physical Therapy stock price valuation
P/E
108.05
P/B
2.97
P/S
2.22
EV/EBIT
38.36
EV/EBITDA
27.07
EV/Sales
2.44
The P/E is 110% higher than the 5-year quarterly average of 51.4 and 21% higher than the last 4 quarters average of 89.5
USPH's EPS is down by 49% YoY and by 12% from the previous quarter
The stock's price to book (P/B) is 26% less than its 5-year quarterly average of 4.0
The stock's P/S is 11% less than its 5-year quarterly average of 2.5 and 3.5% less than its last 4 quarters average of 2.3
U S Physical Therapy's revenue has increased by 9% YoY and by 2.9% from the previous quarter

Efficiency

How efficient is U S Physical Therapy business performance
The ROE is down by 37% YoY and by 11% QoQ
USPH's return on assets is down by 31% year-on-year and by 12% since the previous quarter
USPH's ROS is down by 28% YoY and by 11% from the previous quarter
The ROIC fell by 14% YoY and by 6% QoQ

Dividends

What is USPH's dividend history
DPS
$1.75
Dividend yield
1.84%
Payout ratio
175%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did U S Physical Therapy financials performed over time
The total assets is 187% greater than the total liabilities
The quick ratio has contracted by 37% YoY and by 5% from the previous quarter
The current ratio has contracted by 36% YoY and by 5% from the previous quarter
U S Physical Therapy's debt is 47% less than its equity
U S Physical Therapy's debt has decreased by 2.3% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.